Literature DB >> 5443530

Thymidine kinase as a determinant of the response to 5-fluoro-2'-deoxyuridine in transplantable murine leukemias.

D Kessel, I Wodinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5443530

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  4 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.

Authors:  J S Gronowitz; H Hagberg; C F Källander; B Simonsson
Journal:  Br J Cancer       Date:  1983-04       Impact factor: 7.640

4.  Competitive binding radioassay for the determination of 5-fluorodeoxyuridine and 5-fluorodeoxyuridine-5'-monophosphate levels in plasma and tumor tissue.

Authors:  S Miyata; H Mikami; M Tai; T Hori; H Fujita
Journal:  Jpn J Cancer Res       Date:  1991-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.